APA (7th ed.) Citation

Odnopozova, L., Edin, A., Sukharev, A., Wu, T., Aydin, K., Kelly, M., & Khotko, A. (2022). Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation. Dermatology & Therapy, 12(9), 2063. https://doi.org/10.1007/s13555-022-00776-0

Chicago Style (17th ed.) Citation

Odnopozova, Liudmila, Anton Edin, Alexey Sukharev, Tianshuang Wu, Kerstin Aydin, Maureen Kelly, and Alkes Khotko. "Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation." Dermatology & Therapy 12, no. 9 (2022): 2063. https://doi.org/10.1007/s13555-022-00776-0.

MLA (9th ed.) Citation

Odnopozova, Liudmila, et al. "Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation." Dermatology & Therapy, vol. 12, no. 9, 2022, p. 2063, https://doi.org/10.1007/s13555-022-00776-0.